Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Correspondence

Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer – author’s reply

Hyeyeon Hong, Jonggi Choi

Clin Mol Hepatol. 2024;30(2):272-273. Published online February 21, 2024

DOI: https://doi.org/10.3350/cmh.2024.0123

View: 1828 Download: 75 Crossref: 1

Letter to the Editor

Letter regarding “Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma”

Chi Hsiao, Yung-Po Liaw

Clin Mol Hepatol. 2024;30(1):109-110. Published online October 11, 2023

DOI: https://doi.org/10.3350/cmh.2023.0373

View: 1622 Download: 40

Original Article

Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program

Ming-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, Chi‐Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Kuo-Chih Tseng, Ching-Chu Lo, Ming-Jong Bair, Szu-Jen Wang, Jee-Fu Huang, Ming-Lun Yeh, Chun-Ting Chen, Ming-Chang Tsai, Chien-Wei Huang, Pei-Lun Lee, Tzeng-Hue Yang, Yi-Hsiang Huang, Lee-Won Chong, Chien-Lin Chen, Chi-Chieh Yang, Sheng‐Shun Yang, Pin-Nan Cheng, Tsai-Yuan Hsieh, Jui-Ting Hu, Wen-Chih Wu, Chien-Yu Cheng, Guei-Ying Chen, Guo-Xiong Zhou, Wei-Lun Tsai, Chien-Neng Kao, Chih-Lang Lin, Chia-Chi Wang, Ta-Ya Lin, Chih‐Lin Lin, Wei-Wen Su, Tzong-Hsi Lee, Te-Sheng Chang, Chun-Jen Liu, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wan-Long Chuang, Cheng-Yuan Peng, Chun-Wei- Tsai, Chi-Yi Chen, Ming-Lung Yu

Clin Mol Hepatol. 2024;30(1):64-79. Published online November 21, 2023

DOI: https://doi.org/10.3350/cmh.2023.0287

View: 3712 Download: 133 Crossref: 3

Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide

Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi

Clin Mol Hepatol. 2024;30(1):49-63. Published online November 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0328

View: 2942 Download: 218 Web of Science: 4 Crossref: 6

Review

Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm

Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao

Clin Mol Hepatol. 2023;29(4):869-890. Published online March 14, 2023

DOI: https://doi.org/10.3350/cmh.2022.0420

View: 3743 Download: 211 Web of Science: 5 Crossref: 10

Original Article

Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma

Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee

Clin Mol Hepatol. 2023;29(3):794-809. Published online May 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0057

View: 3771 Download: 154 Web of Science: 1 Crossref: 1

Editorial

Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers

Lilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip

Clin Mol Hepatol. 2023;29(1):113-117. Published online October 31, 2022

DOI: https://doi.org/10.3350/cmh.2022.0333

View: 3347 Download: 105 Web of Science: 3 Crossref: 4

Original Article

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis

Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, Chun-Jen Liu, Ching-Chu Lo, Ke-Jhang Huang, Jyh-Jou Chen, Kuo-Chih Tseng, Chi-Yang Chang, Cheng-Yuan Peng, Yu-Lueng Shih, Chia-Sheng Huang, Wei-Yu Kao, Sheng-Shun Yang, Ming-Chang Tsai, Jo-Hsuan Wu, Po-Yueh Chen, Pei-Yuan Su, Jow-Jyh Hwang, Yu-Jen Fang, Pei-Lun Lee, Chi-Wei Tseng, Fu-Jen Lee, Hsueh-Chou Lai, Tsai-Yuan Hsieh, Chun-Chao Chang, Chung-Hsin Chang, Yi-Jie Huang, Jia-Horng Kao

Clin Mol Hepatol. 2021;27(4):575-588. Published online July 13, 2021

DOI: https://doi.org/10.3350/cmh.2021.0155

View: 10042 Download: 1,006 Web of Science: 10 Crossref: 10

The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients

Yu Jun Wong, Prem Harichander Thurairajah, Rahul Kumar, Kwong Ming Fock, Ngai Moh Law, Sin-Yoong Chong, Fria Gloriba Manejero, Tiing-Leong Ang, Eng Kiong Teo, Jessica Tan

Clin Mol Hepatol. 2021;27(3):474-485. Published online February 19, 2021

DOI: https://doi.org/10.3350/cmh.2021.0015

View: 6988 Download: 139 Web of Science: 10 Crossref: 10

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B

Mi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim

Clin Mol Hepatol. 2021;27(2):295-304. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0216

View: 5824 Download: 212 Web of Science: 20 Crossref: 24

Review

Current and future strategies for the treatment of chronic hepatitis C

Omar Alshuwaykh, Paul Y. Kwo

Clin Mol Hepatol. 2021;27(2):246-256. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0230

View: 6354 Download: 241 Web of Science: 14 Crossref: 15

Original Article

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis

Po-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, Sheng-Wen Niu, Jiun-Chi Huang, Cheng-Ting Hsu, Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Szu-Chia Chen, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Jer-Ming Chang, Shang-Jyh Hwang, Wan-Long Chuang, Chung-Feng Huang, Yi-Wen Chiu, Ming-Lung Yu

Clin Mol Hepatol. 2021;27(1):186-196. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0180

View: 7656 Download: 216 Web of Science: 13 Crossref: 12

Editorial

Drug-drug interactions with direct-acting antivirals — less is more

Grace Lai-Hung Wong

Clin Mol Hepatol. 2021;27(1):81-82. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0278

View: 4035 Download: 103 Web of Science: 1 Crossref: 1

More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis

Paul Kwo, Deepti Dronamraju

Clin Mol Hepatol. 2020;26(4):489-491. Published online September 24, 2020

DOI: https://doi.org/10.3350/cmh.2020.0228

View: 4227 Download: 73 Web of Science: 1 Crossref: 1

Original Article

An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection

Youn Jae Lee, Jeong Heo, Do Young Kim, Woo Jin Chung, Won Young Tak, Yoon Jun Kim, Seung Woon Paik, Eungeol Sim, Susila Kulasingam, Rohit Talwani, Barbara Haber, Peggy Hwang

Clin Mol Hepatol. 2019;25(4):400-407. Published online May 28, 2019

DOI: https://doi.org/10.3350/cmh.2019.0006

View: 6556 Download: 127 Web of Science: 9 Crossref: 7

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir

David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim

Clin Mol Hepatol. 2019;25(3):283-293. Published online November 13, 2018

DOI: https://doi.org/10.3350/cmh.2018.0054

View: 10673 Download: 248 Web of Science: 30 Crossref: 35

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients

Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht

Clin Mol Hepatol. 2019;25(1):42-51. Published online November 19, 2018

DOI: https://doi.org/10.3350/cmh.2018.0029

View: 10693 Download: 124 Web of Science: 13 Crossref: 14

Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them

Kwang Il Seo, Si Hyun Bae, Pil Soo Sung, Chung-Hwa Park, Hae Lim Lee, Hee Yeon Kim, Hye Ji Kim, Bo Hyun Jang, Jeong Won Jang, Seung Kew Yoon, Jong Young Choi, In-Yang Park, Juyoung Lee, Hyun Seung Lee, Sa-Jin Kim, Jung Hyun Kwon, U Im Chang, Chang Wook Kim, Se Hyun Jo, Young Lee, Fisseha Tekle, Jong-Hyun Kim

Clin Mol Hepatol. 2018;24(4):374-383. Published online June 26, 2018

DOI: https://doi.org/10.3350/cmh.2017.0082

View: 9089 Download: 335 Web of Science: 1

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling

Pil Soo Sung, Eun Byul Lee, Dong Jun Park, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol. 2018;24(3):302-310. Published online March 12, 2018

DOI: https://doi.org/10.3350/cmh.2017.0074

View: 10093 Download: 185 Web of Science: 18 Crossref: 18

Current status of Liver diseases in Korea: Hepatitis B

Hee Bok Chae , Jong Hyun Kim , Ja Kyung Kim , Hyung Joon Yim

Clin Mol Hepatol. 2009;15(60):13-24. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.S6.S13

View: 8419 Download: 99 Crossref: 75

3

Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea

Byung Kook Kim, M.D., So Young Kwon, M.D., Chang Hong Lee, M.D., Won Hyeok Choe, M.D., Hong Mi Choi, M.S. Hye Won Koo, M.D.

Clin Mol Hepatol. 2009;15(1):25-41. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.25

View: 5429 Download: 55 Crossref: 3

2

Treatment of Chronic Hepatitis B ; Antiviral Therapy in Hepatitis B Carriers Undergoing Immunosuppressive Treatment or Cytotoxic Chemotherapy

Jung Hwan Yoon

Clin Mol Hepatol. 2005;11(1):17-20. Published online January 1, 2000

View: 2385 Download: 12

1 |

Viewed By 4992	MAFLD: How is it different from NAFLD?
Viewed By 4841	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4772	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4490	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4442	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 95	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search